Project

CT-Luso is a Project for Ethical and Regulatory Capacity Building in Clinical Trials in Portuguese-speaking African Countries (PALOP) – Angola, Cape Verde, Guinea-Bissau, Mozambique, and São Tomé and Príncipe – in partnership with Portugal. It is approved and funded by the Europe and Developing Countries Partnership for Clinical Trials (EDCTP3) Program with support from the European Union (EU), running from September 1st, 2024, to December 30th, 2027.

This project was built as a continuation and ambitious development of the goals achieved by BERC-Luso, an Ethical and Regulatory Capacity Building Project in Portuguese-speaking African Countries, approved and funded by the EDCTP2 Program and the Calouste Gulbenkian Foundation, which ran from 2018 to 2022.